by McDermott + Bull | Sep 5, 2023 | Andrea Richter, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Mallory McDermott, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed John Schellhorn as Chief Executive Officer at Vibrant Gastro. In this vital role, John will be responsible for steering the company’s strategic direction, overseeing business operations, and leading the development and...
by McDermott + Bull | Aug 31, 2023 | Brian Selvey, Chase Mitchell, Craig Lipus, Craig Lipus Placement Announcement, Garrett Lipus, Garrett Lipus Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Lipus
McDermott + Bull has successfully placed Eric Priester as Chief Financial Officer at private equity-backed Ensemble Therapy. Eric will lead the day-to-day finance and accounting activities of the company while supporting the growth of the business. Eric has a strong...
by McDermott + Bull | Jul 17, 2023 | Brian Selvey, Chase Mitchell, Craig Lipus, Craig Lipus Placement Announcement, Garrett Lipus, Garrett Lipus Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed Michael Zuckerman as Chief Executive Officer at private equity-backed Ensemble Therapy. Michael will work closely with the private equity firm Carroll Capital to enhance the company’s platform, drive scalability, and build...
by McDermott + Bull | Jul 10, 2023 | Brittany Stansfield, Brittany Stansfield Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Paul Gibbons, Paul Gibbons Placement Announcement, Placement Announcement, Private Equity, Private Equity Placement Announcement
McDermott + Bull has successfully placed Brian Sill as Chief Financial Officer at Nuance Medical. In this role, Brian will be instrumental in shaping the company’s financial trajectory as its inaugural CFO. He will oversee the development and expansion of the finance,...
by McDermott + Bull | Jun 27, 2023 | Allison Cox, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement, Shelby Varon, Shelby Varon Placement Announcement
McDermott + Bull has successfully placed Joshua (Josh) Woolley as Vice President of Clinical Affairs and Regulatory at Aria CV. Josh will be responsible for launching the company’s early feasibility study and leading ongoing engagements with the FDA to drive product...
by McDermott + Bull | Jun 26, 2023 | Anne Terry, Chris Bull, Chris Bull Placement Announcement, CJ Shook, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Isabelle Karl, Julia Markward, Placement Announcement
McDermott + Bull has successfully placed David O’Toole as Chief Financial Officer at AVITA Medical (NASDAQ: RCEL, ASX: AVH). David will report to and work closely with the CEO, serving as a valued member of the executive leadership team. In this role, he will provide...
